Literature DB >> 29945277

Pre-Treatment with Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats.

Vivian Soetikno1, Shinta Dewi Permata Sari1, Lulu Ul Maknun1, Nielda Kezia Sumbung1, Deliana Nur Ihsani Rahmi1, Bashar Adi Wahyu Pandhita1, Melva Louisa1, Ari Estuningtyas1.   

Abstract

OBJECTIVE: In addition to oxidative stress, inflammation and apoptosis have an important role in the pathogenesis of cisplatin-induced kidney damage. This study aimed to investigate the molecular mechanisms of protective effects of curcumin against cisplatin-induced kidney inflammation and apoptosis in rats.
MATERIALS AND METHODS: Eighteen rats were equally divided into three groups; normal (0.5% CMC-Na), cisplatin (CDPP) (7 mg/kg i.p.), and cisplatin+curcumin (CMN100) groups. Curcumin was given at a dose of 100 mg/kg orally for nine days, starts one week before giving a single dose of cisplatin. Kidney and plasma were taken for analysis.
RESULTS: Cisplatin challenged rats demonstrated kidney injury as shown by reduced creatinine clearance, increased of plasma BUN, plasma creatinine, and kidney MDA, decreased of kidney GSH levels, and kidney histopathology alterations. Also, cisplatin increased ERK1/2 phosphorylation and NF-κB expression, which subsequently increased mRNA expression of TNF-α, IL-6, KIM-1, NGAL, and Bax/Bcl-2 ratio as well as decreased mRNA expression of IL-10 in kidney tissues. Pre-treatment with curcumin significantly ameliorated inflammation and apoptosis induced by cisplatin. In addition, curcumin downregulated Ctr1 and OCT2 drug transporters as compared to cisplatin group. Histopathological examination furthers confirmed the kidney damage protection effect of curcumin.
CONCLUSIONS: These data indicate that curcumin has nephroprotective properties against cisplatin-induced kidney damage in rats and this effect is associated with its anti-inflammatory and anti-apoptosis profiles, in addition to its antioxidant. Hence, curcumin may be useful for preventing kidney damage against cisplatin administration. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29945277     DOI: 10.1055/a-0641-5148

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  9 in total

1.  Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism.

Authors:  Thikryat Neamatallah; Nagla El-Shitany; Aymn Abbas; Basma G Eid; Steve Harakeh; Soad Ali; Shaker Mousa
Journal:  Molecules       Date:  2020-07-02       Impact factor: 4.411

Review 2.  Toll-Like Receptors in Acute Kidney Injury.

Authors:  Cristina Vázquez-Carballo; Melania Guerrero-Hue; Cristina García-Caballero; Sandra Rayego-Mateos; Lucas Opazo-Ríos; José Luis Morgado-Pascual; Carmen Herencia-Bellido; Mercedes Vallejo-Mudarra; Isabel Cortegano; María Luisa Gaspar; Belén de Andrés; Jesús Egido; Juan Antonio Moreno
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

3.  TRPA1 promotes cisplatin-induced nephrotoxicity through inflammation mediated by the MAPK/NF-κB signaling pathway.

Authors:  Jinyan Yuan; Xiao Liang; Wei Zhou; Jing Feng; Zhenyang Wang; Shaoxian Shen; Xin Guan; Liangbin Zhao; Fei Deng
Journal:  Ann Transl Med       Date:  2021-10

Review 4.  Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking.

Authors:  Wei Zou; Birui Shi; Ting Zeng; Yan Zhang; Baolin Huang; Bo Ouyang; Zheng Cai; Menghua Liu
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

5.  Mechanistic insights into the renoprotective role of curcumin in cisplatin-induced acute kidney injury: network pharmacology analysis and experimental validation.

Authors:  Zhang Hui; Qing-Qing Dong; Hua-Pan Shu; Yu-Chi Tu; Qian-Qian Liao; Li-Jun Yao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.

Authors:  Agian Jeffilano Barinda; Wawaimuli Arozal; Ni Made Dwi Sandhiutami; Melva Louisa; Nur Arfian; Normalina Sandora; Muhammad Yusuf
Journal:  Adv Pharm Bull       Date:  2020-09-19

Review 7.  Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review.

Authors:  Bingqian Li; Huili Shao; Lei Gao; Huan Li; Huagang Sheng; Liqiao Zhu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

8.  Regulated cell death in cisplatin-induced AKI: relevance of myo-inositol metabolism.

Authors:  Fei Deng; Xiaoping Zheng; Isha Sharma; Yingbo Dai; Yinhuai Wang; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-22

9.  Comparative Effect of Curcumin and Nanocurcumin on Nephroprotection at Cisplatin-induced Rats.

Authors:  Ni Made D Sandhiutami; Wawaimuli Arozal; Melva Louisa; Deni Rahmat; Tjoeng Mandy
Journal:  J Pharm Bioallied Sci       Date:  2019-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.